An unusual case of aplastic anemia caused by temozolomide

Case Reports in Medicine

Volumn 2010, Issue , 2010, Pages

  Comez, Gazi ^a   Sevinc, Alper ^a   Sever, Ozlem Nuray ^a   Babacan, Taner ^a   Sari, Ibrahim ^a   Camci, Celalettin ^a  

^a GAZIANTEP UNIVERSITY   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84867574935     PISSN: 16879627     EISSN: 16879635     Source Type: Journal    
DOI: 10.1155/2010/975039     Document Type: Article

References (7)

1. R. Stupp, M. Gander, S. Leyvraz, and E. Newlands, "Current and future developments in the use of temozolomide for the treatment of brain tumours," Lancet Oncology, vol. 2, no. 9, pp. 552-560, 2001. (Pubitemid 33586868)
2. R. Stupp, W. P. Mason, M. J. Van Den Bent et al., "Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma," New England Journal of Medicine, vol. 352, no. 10, pp. 987-996, 2005. (Pubitemid 40349501)
3. A. Birner, "Pharmacology of oral chemotherapy agents," Clinical Journal of Oncology Nursing, vol. 7, no. 6, supplement, pp. 11-19, 2003.
4. D. E. Gerber, S. A. Grossman, M. Zeltzman, M. A. Parisi, and L. Kleinberg, "The impact of thrombocytopenia from temozolomide and radiation in newly diagnosed adults with high-grade gliomas," Neuro-Oncology, vol. 9, no. 1, pp. 47-52, 2007. (Pubitemid 46543488)
5. N. S. Young, "Acquired aplastic anemia," Annals of Internal Medicine, vol. 136, no. 7, pp. 534-546, 2002.
6. J. Doyle, T. Mikkelsen, D. Croteau et al., "Fatal hematologic toxicity with prolonged continuous administration of temozolamide (TMZ) during radiation therapy (RT) in the treatment of newly-diagnosed glioblastomamultiforme (GBM): report of a Phase II trial," Journal of Clinical Oncology, vol. 23, article 1546, 2005.
7. J. L. Villano, C. A. Collins, E. E. Manasanch, C. Ramaprasad, and K. van Besien, "Aplastic anaemia in patient with glioblastoma multiforme treated with temozolomide," Lancet Oncology, vol. 7, no. 5, pp. 436-438, 2006.